SEQ-IT reports breakthrough in the rapid variant diagnosis of SARS-CoV-2
Share: Kaiserslautern, Germany, February 22, 2021 – SEQ-IT, a leading molecular services provider, today announced they completed a novel mass spectrometry based rapid test for the detection of 20 of the most relevant SARS-CoV-2 mutations including the UK (B.1.1.7), South African and Brazilian variants. The test panel was developed using Agena Bioscience's MassARRAY® System, a well-established tool used by clinical laboratories worldwide to deliver affordable, highly accurate genomic testing. "SEQ-IT has been heavily involved in the COVID-19 pandemic response since its beginning. We strive...
Source: benzinga.com